VOYA Investment Management’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$760K Sell
11,265
-3,081
-21% -$187K ﹤0.01% 1634
2026
Q1
$796K Buy
14,346
+1,586
+12% +$85.3K ﹤0.01% 1535
2025
Q4
$619K Sell
12,760
-201
-2% -$7.83K ﹤0.01% 1662
2025
Q3
$397K Sell
12,961
-60,044
-82% -$1.38M ﹤0.01% 1872
2025
Q2
$1.62M Sell
73,005
-23,967
-25% -$502K ﹤0.01% 1381
2025
Q1
$1.8M Buy
+96,972
New +$1.62M ﹤0.01% 1347
2024
Q4
Sell
-6,602
Closed -$221K 2735
2024
Q3
$221K Buy
+6,602
New +$226K ﹤0.01% 2428
2023
Q1
Sell
-8,281
Closed -$257K 2886
2022
Q4
$257K Hold
8,281
﹤0.01% 2432
2022
Q3
$211K Buy
+8,281
New +$194K ﹤0.01% 2578
2022
Q1
Sell
-7,780
Closed -$270K 2652
2021
Q4
$270K Sell
7,780
-714
-8% -$22.6K ﹤0.01% 2353
2021
Q3
$230K Hold
8,494
﹤0.01% 2488
2021
Q2
$220K Sell
8,494
-1,172
-12% -$28.1K ﹤0.01% 2553
2021
Q1
$208K Buy
+9,666
New +$244K ﹤0.01% 2521
2020
Q2
Sell
-11,957
Closed -$169K 2509
2020
Q1
$169K Hold
11,957
﹤0.01% 2189
2019
Q4
$194K Buy
11,957
+2,623
+28% +$62K ﹤0.01% 2383
2019
Q3
$327K Hold
9,334
﹤0.01% 1996
2019
Q2
$527K Buy
9,334
+756
+9% +$54.4K ﹤0.01% 1739
2019
Q1
$627K Hold
8,578
﹤0.01% 1642
2018
Q4
$547K Buy
8,578
+1,044
+14% +$77.6K ﹤0.01% 1661
2018
Q3
$752K Hold
7,534
﹤0.01% 1585
2018
Q2
$535K Sell
7,534
-308
-4% -$25.8K ﹤0.01% 1781
2018
Q1
$816K Hold
7,842
﹤0.01% 1498
2017
Q4
$790K Buy
+7,842
New +$577K ﹤0.01% 1565

Other funds holding ANAB

VOYA Investment Management's ANAB Position: Q2 2026 in Review

VOYA Investment Management reduced its AnaptysBio (ANAB) stake by 21% in Q2 2026, selling an estimated $187K and leaving 11,265 shares worth $760K. The position accounts for ﹤0.01% of the portfolio, ranked #1634.

VOYA Investment Management first reported a position in ANAB in Q4 2017 and has held it in 23 quarters since. The position peaked at $1.8M in Q1 2025. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • VOYA Investment Management held 11,265 shares of AnaptysBio worth $760K as of Q2 2026.
  • VOYA Investment Management sold 3,081 AnaptysBio shares in Q2 2026, an estimated $187K.
  • AnaptysBio made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #1634 holding.
  • VOYA Investment Management first reported a position in AnaptysBio in Q4 2017 and has held it in 23 quarters since.
  • VOYA Investment Management's AnaptysBio position peaked at $1.8M in Q1 2025.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.